Gastrointestinal Agents Felix Hernandez, M.D.. Acid Reducing Agents Histamine Receptor Blockers: Histamine Receptor Blockers: MOA: Histamine receptor.

Slides:



Advertisements
Similar presentations
Gastrointestinal Drugs
Advertisements

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 79 Laxatives.
GI Drugs PHC 5409B Dr. T.C. Peterson.
Drugs Affecting the Gastrointestinal System
Definitions: Stomach or duodenal mucosal lesions
Antacids L. Scheffler 1.
Antacids & Acid-Controlling Agents
Drugs Used For Peptic Ulcer
Drugs Used For Peptic Ulcer
Topics Background Treatment Reading Assignments/Questions References
Gastrointestinal Medications
Drugs acting on the Gastrointestinal Tract:- Gastrointestinal diseases is a common clinical problem in veterinary practice, and accurate diagnosis is essential.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 50 Antidiarrheals and Laxatives.
1 Chapter 8 Drugs for Gastrointestinal Disorders.
Drugs to Treat Gastrointestinal Disorders. Clinical Indication Prevention or management of gastric or duodenal ulcers Management of gastroesophageal reflux.
Gastrointestinal Pharmacology Prof. Sri Agus Sudjarwo.,Ph.D
GASTRO-INTESTINAL DRUGS
PTP 546 Module 12: Gastrointestinal Pharmacology Jayne Hansche Lobert, MS, RN, ACNS-BC, NP 1Lobert.
Drugs Used in Gastrointestinal System Prof. : Abdulqader A. ALHAIDER.
Drugs Acting On Gastrointestinal Tract Gastrointestinal Tract Professor Kassim Al-Saudi, M.B.,Ch.B.,Ph.D.
CHAPTER 49 Acid-Controlling Agents
(H2 blockers and proton pump inhibitors)
Anti Ulceration and Anti Emetics Nur Irjawati S. Kawang, S.Si,
Drugs for diarrhea & constipation. Diarrhea Causes of diarrhea Nonpharmacologic measures Traveler’s diarrhea –Frequent cause: Escherichia coli –Preventive.
Chapter 26 Laxatives and Antidiarrheals. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Laxative.
Drugs for Treating GI Disorders Chapter 11. GI Disorders  Peptic Ulcer and Acid Reflux Disorders  Laxatives and Cathartics  Antidiarrheals  Antiemetics.
Pharmacology In Nursing GI Medications
Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease
Chapter 24 Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease.
Mosby items and derived items © 2005, 2002 by Mosby, Inc.
Digestants & Drugs Affecting Gallbladder Promote the process of digestion in GI tract pancrealipase (Pancrease) - contains digestive enzymes Side effect:
Block 1 Pharm Cameron Blair & Josh Solomon. Learning outcomes Mechanisms of action, S/E & examples of: O Drugs that protect the stomach O Anti-diarrhoeal.
Gastrointestinal Pharmacology
ADSORBENTS & LAXATIVE By Wiwik Kusumawati. OBJECTIVE At the end of this topic the students will be able to : At the end of this topic the students will.
GI Diseases Review 30 November :04 AM.
ANTIULCER MEDICATIONS Causes of ulcers: gastric hyperacidity, bile reflux from duodenum to stomach, accumulation of toxins in the blood (renal failure),
Pharmacology of drugs affecting GIT
PYRAMID POINTS CHAPTER 56: GASTROINTESTINAL MEDICATIONS.
Laxative and anti-diarrheal
 DRUGS USED TO TREAT GASTROESOPHAGEAL REFLUX DISEASE AND ULCER DISEASE sh.alinia3.
GASTROINTESTINAL DRUGS KIM EASTMAN, RN, MSN, CNS.
Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Diseases
Laxatives and Antidiarrheals
Agents Used to Treat Hyperacidity and Gastroesophageal Reflux Disease
Drugs in peptic ulcer (H 2 blockers and proton pump inhibitors) By Prof. Hanan Hagar.
GI MEDICATIONS BY: RANDY BONNELL. ANTACIDS  TRADE: MAALOX, MYLANTA, TITRALAC  ACTION: NEUTRALIZES GASTRIC ACIDS  SIDE EFFECTS: CONSTIPATION, SODIUM.
Pharmacology. Peptic Ulcer Disease Imbalance between mucosal defensive factors and aggressive factors Major defensive – mucus and bicarbonate Major aggressive.
Gastronintestinal Issues and Management  What are the primary areas of concern for the patient with any stomach disorder?  Major stomach disorders Iggy.
GI Meds Chapters 40 and 42. What is Important About GI Meds? Objectives: Know conditions used for Know goals for treatment Identify classification of.
ACID-PEPTIC DISEASE AND TREATMENT Introduction - A. Acid peptic includes: 1.Peptic ulcers (stomach and duodenal) 2.Gastroesophageal reflux disorders (GERD)
LAXATIVES AND CATHARTICS
Medications Used for Gastrointestinal System Disorders
Chapter 33 Therapy of Gastrointestinal Disorders: Peptic Ulcers, GERD, and Vomiting.
L. Scheffler with additional material by A J Hennigan!
Jeopardy Final Jeopardy Antacids Antiemetics/ Emetics $100 $100 $100
Antacids 1.
Drugs for Gastrointestinal and Related Diseases
Gastrointestinal Pharmacology
NCLEX Pharmacology Quiz on Respiratory & Gastrointestinal Drugs
Laxative and anti-diarrheal
Drugs in peptic ulcer (H2 blockers and proton pump inhibitors)
Drugs for Peptic Ulcer Disease
Histamine-2 receptor antagonists
Antidiarrheals Major factors in diarrhea
Digestants & Drugs Affecting Gallbladder
Gastrointestinal Agents
Acid-peptic disease   A group of disorders involving erosion or ulceration of the mucosal lining of the gastrointestinal tract; includes GERD, gastric.
DRUGS FOR GI DISORDERS CHAPTER 8. GI Disorders COMMON DISEASES OF GI SYTEM INCLUDES Peptic Ulcer and Acid Reflux Disorders Laxatives and Cathartics.
Histamine-2 Receptor Antagonists and Proton Pump Inhibitors (PPIs)
Presentation transcript:

Gastrointestinal Agents Felix Hernandez, M.D.

Acid Reducing Agents Histamine Receptor Blockers: Histamine Receptor Blockers: MOA: Histamine receptor Antagonist MOA: Histamine receptor Antagonist Indications: duodenal/gastric ulcer, hypersecretion of acid, GERD Indications: duodenal/gastric ulcer, hypersecretion of acid, GERD Side Effects: Well tolerated. Diarrhea, decreased libido, impotence. Can be hepatotoxic and renal toxic Side Effects: Well tolerated. Diarrhea, decreased libido, impotence. Can be hepatotoxic and renal toxic Interactions: increases concentration of anticoagulants Interactions: increases concentration of anticoagulants Drugs: Drugs: Cimetidine (Tagamet) Cimetidine (Tagamet) Ranitidine (Zantac) Ranitidine (Zantac) Famotidine (Pepcid) Famotidine (Pepcid)

Acid Reducing Agents Antacids Antacids Aluminum Salts Aluminum Salts MOA: Neutralize gastric acid thus causing a reduction in mucosal irritation. Relief of pain precedes healing. MOA: Neutralize gastric acid thus causing a reduction in mucosal irritation. Relief of pain precedes healing. Indications: symptomatic relief of gastric acid irritation Indications: symptomatic relief of gastric acid irritation Side Effects: constipation, hypercalcemia, hypophosphatemia Side Effects: constipation, hypercalcemia, hypophosphatemia Notes: Magnesium antacids are co administered to prevent constipation Notes: Magnesium antacids are co administered to prevent constipation Calcium Carbonate Calcium Carbonate MOA: same MOA: same Indications: same Indications: same Side effects: constipation, hypercalcemia, metabolic alkalosis, milk-alkali syndrome (rare) Side effects: constipation, hypercalcemia, metabolic alkalosis, milk-alkali syndrome (rare) Magnesium Salts Magnesium Salts MOA: same MOA: same Indications: same Indications: same Side Effects: diarrhea, hypermagnesemia  N/V, hyporeflexia, decreased muscle tone Side Effects: diarrhea, hypermagnesemia  N/V, hyporeflexia, decreased muscle tone Sodium Citrate Sodium Citrate MOA: same MOA: same Indications: Pre-op antacid Indications: Pre-op antacid Side Effects: Horrible taste but is likely to cause aspiration pneumonitis because it is nonparticulate Side Effects: Horrible taste but is likely to cause aspiration pneumonitis because it is nonparticulate

Acid Reducing Agents Sucralfate (Carafate) Sucralfate (Carafate) MOA: Sucrose and polyaluminum hydroxide polymerize at low pH to form a protective coating MOA: Sucrose and polyaluminum hydroxide polymerize at low pH to form a protective coating Indications: Prophylaxis and treatment of duodenal ulcers Indications: Prophylaxis and treatment of duodenal ulcers Side Effects: Constipation Side Effects: Constipation Interferes with the absorption of fluroquinolone AB Interferes with the absorption of fluroquinolone AB

Proton Pump Inhibitors Drugs: Omeprazole (Prilosec), Lansoprazole (Prevacid), Esomeprazole (Nexium), Pantoprazole (Protonix) Drugs: Omeprazole (Prilosec), Lansoprazole (Prevacid), Esomeprazole (Nexium), Pantoprazole (Protonix) MOA: inhibits hydrogen/potassium ATPase (Proton pump) of the parietal cells thus reducing acid secretion. MOA: inhibits hydrogen/potassium ATPase (Proton pump) of the parietal cells thus reducing acid secretion. Indications: reflux esophagitis, duodenal ulcers, hypersecretory states Indications: reflux esophagitis, duodenal ulcers, hypersecretory states Side Effects: Constipation (few side effects) Side Effects: Constipation (few side effects) Omeprazole interacts with warfarin, phenytoin and diazepam Omeprazole interacts with warfarin, phenytoin and diazepam

Dysmotility Agent Metoclopramide (Reglan) Metoclopramide (Reglan) MOA: increases rate of gastric emptying by an unknown mechanism MOA: increases rate of gastric emptying by an unknown mechanism Indications: reflux esophagitis, gastroparesis, pre-op gastric emptying Indications: reflux esophagitis, gastroparesis, pre-op gastric emptying Side Effects: diarrhea, constipation, can cause extra-pyramidal side effects due to dopamine antagonism (elderly and children) Side Effects: diarrhea, constipation, can cause extra-pyramidal side effects due to dopamine antagonism (elderly and children) Increases the toxicity of antipsychotics Increases the toxicity of antipsychotics

Mucosal Protectant Misoprostol Misoprostol MOA: increases bicarbonate and mucin release in the GI tract and reduces acid secretion MOA: increases bicarbonate and mucin release in the GI tract and reduces acid secretion Indications: prevention of ulcers caused by aspirin and other NSAIDS Indications: prevention of ulcers caused by aspirin and other NSAIDS Side Effects: Abortion (uterine contraction), diarrhea, abdominal pain, flatulence Side Effects: Abortion (uterine contraction), diarrhea, abdominal pain, flatulence Contraindications: PREGNANCY!!!! Contraindications: PREGNANCY!!!! Is a prostaglandin analog Is a prostaglandin analog

Antidiarrheal Agents Opiates Opiates Diphenoxylate and Atropine (Lomotil) Diphenoxylate and Atropine (Lomotil) MOA: diphenoxylate is an agonist at opiate receptors in the GI tract and atropine blocks muscarinic receptors. Both of these actions inhibit peristalsis MOA: diphenoxylate is an agonist at opiate receptors in the GI tract and atropine blocks muscarinic receptors. Both of these actions inhibit peristalsis Indications: Diarrhea Indications: Diarrhea Side Effects: few such as constipation, abdominal/bowel distention Side Effects: few such as constipation, abdominal/bowel distention Contraindications: Parasitic or bacterial infections, obstructive jaundice Contraindications: Parasitic or bacterial infections, obstructive jaundice Increased risk of paralytic ileus with antimuscarinics Increased risk of paralytic ileus with antimuscarinics Loperamide (Imodium) Loperamide (Imodium) No drug interactions No drug interactions Treat OD with Naloxone Treat OD with Naloxone

Antidiarrheal Agents Absorbents Absorbents Bismuth Subsalicylate (Pepto-Bismol) Bismuth Subsalicylate (Pepto-Bismol) MOA: absorbs toxins produced by bacteria and other GI irritants MOA: absorbs toxins produced by bacteria and other GI irritants Indications: Diarrhea, prophylaxis for traveler’s diarrhea Indications: Diarrhea, prophylaxis for traveler’s diarrhea Side Effects: Impaction Side Effects: Impaction Contraindications: Aspirin sensitivity Contraindications: Aspirin sensitivity Potentiates oral anticoagulants Potentiates oral anticoagulants Kaolin/Pectin (Kaopectate) Kaolin/Pectin (Kaopectate) MOA: adsorbent and protection that is of questionable efficacy MOA: adsorbent and protection that is of questionable efficacy Indications: diarrhea Indications: diarrhea Side effects: may increase potassium loss or interfere with absorption of drugs and nutrients Side effects: may increase potassium loss or interfere with absorption of drugs and nutrients Contraindications: obstructive bowel lesions Contraindications: obstructive bowel lesions

Antidiarrheal Agents Cholestyramine (Questran) Cholestyramine (Questran) MOA: absorbs bile salts (they cause diarrhea) and C. difficile toxin MOA: absorbs bile salts (they cause diarrhea) and C. difficile toxin Indications: Diarrhea caused by C. difficile or bile acids Indications: Diarrhea caused by C. difficile or bile acids Side Effects: constipation Side Effects: constipation Mainly used for lipid disorders Mainly used for lipid disorders

Inflammatory Bowel Agents Mesalamine and Sulfasalazine Mesalamine and Sulfasalazine MOA: anti inflammatory MOA: anti inflammatory Indications: inflammatory bowel syndrome, UC or Crohn’s Indications: inflammatory bowel syndrome, UC or Crohn’s Will cover more of this drug in a later chapter Will cover more of this drug in a later chapter

Bulk Forming Agents Psyllium (Metamucil) Psyllium (Metamucil) MOA: nondigested plant cell wall absorbs water into feces thus softening the stool MOA: nondigested plant cell wall absorbs water into feces thus softening the stool Indications: constipation, hard stools Indications: constipation, hard stools Side Effects: flatulence, impaction if the bolus is obstructed Side Effects: flatulence, impaction if the bolus is obstructed

Stimulant Laxatives Bisacodyl (Dulcolax) Bisacodyl (Dulcolax) MOA: increases water and electrolytes in feces and increases intestinal motility MOA: increases water and electrolytes in feces and increases intestinal motility Side Effects: continuous use may cause diarrhea Side Effects: continuous use may cause diarrhea

Milk of Magnesia Milk of Magnesia (saline solutions) Milk of Magnesia (saline solutions) MOA: magnesium or sodium salts are poorly absorbed and thus draw water into the lumen. MOA: magnesium or sodium salts are poorly absorbed and thus draw water into the lumen. High dose rids bowel of parasites and empties bowel preoperatively High dose rids bowel of parasites and empties bowel preoperatively Side Effects: precipitation of cardiac, renal, convulsive disorders or hypocalcaemia Side Effects: precipitation of cardiac, renal, convulsive disorders or hypocalcaemia

Castor Oil MOA: metabolized in the intestine to ricinoleate. It is a surfactant which decreases water and electrolyte absorption and increases motility MOA: metabolized in the intestine to ricinoleate. It is a surfactant which decreases water and electrolyte absorption and increases motility Side Effects: cramps. Chronic use must be avoided due the risk of dehydration, electrolyte imbalance and nerve damage Side Effects: cramps. Chronic use must be avoided due the risk of dehydration, electrolyte imbalance and nerve damage

Polyethylene Glycol (MiraLax) MOA: hyperosmolarity draws water into the colon MOA: hyperosmolarity draws water into the colon Side Effects: cramps, N, bloating Side Effects: cramps, N, bloating

Lactulose (Chronulac) MOA: Hyperosmolarity draws water into the colon. Gets metabolized in the intestine to lactate which acts as a laxative osmotically and by lowering the pH MOA: Hyperosmolarity draws water into the colon. Gets metabolized in the intestine to lactate which acts as a laxative osmotically and by lowering the pH Side Effects: cramps, flatulence, N/V Side Effects: cramps, flatulence, N/V

Mineral Oil MOA: Lubricates feces and prevents absorption of water from feces MOA: Lubricates feces and prevents absorption of water from feces Side Effects: anal leakage and irritation, reduces vitamin absorption Side Effects: anal leakage and irritation, reduces vitamin absorption Can develop aspiration pneumonitis with oral administration Can develop aspiration pneumonitis with oral administration

Docusate (Colace) MOA: improves penetration of water and fat into feces MOA: improves penetration of water and fat into feces Side Effects: diarrhea, abdominal cramps. Side Effects: diarrhea, abdominal cramps. It increases the absorption of mineral oil so do not use together with mineral oil It increases the absorption of mineral oil so do not use together with mineral oil

Obesity Management Orlistat (Xenical) Orlistat (Xenical) MOA: reversible lipase inhibitor therefore it inhibits the absorption of fats from the intestine MOA: reversible lipase inhibitor therefore it inhibits the absorption of fats from the intestine Should be accompanied by a balanced reduced calorie diet Should be accompanied by a balanced reduced calorie diet Multivitamin supplements are needed because vitamin absorption is decreased by the drug Multivitamin supplements are needed because vitamin absorption is decreased by the drug Patient will have fatty/oily stool Patient will have fatty/oily stool